Abstract
Objective
To determine whether the placement of an implantable cardioverter–defibrillator (ICD) lead in the right ventricular outflow tract (RVOT) has the same defibrillation threshold (DFT) as the right ventricular apex (RVA).
Background
Right ventricular ICD leads have usually been placed in the RVA. Development of active fixation technology has allowed the placement of these leads in alternate locations such as the RVOT.
Methods
At time of device implantation, 26 patients with either ischemic or dilated cardiomyopathy underwent DFT testing in both the RVA and RVOT using a binary search algorithm.
Results
Placement of the lead in the RVA had a mean DFT of 7.6 ± 2.8 J while the placement of the lead in the RVOT had a mean DFT of 10.3 ± 3.0 J. The median (25th and 75th percentiles) DFTs in the RVA and RVOT were 7.5 J (6 and 11 J) and 11 J (9 and 14 J), respectively (p = 0.0002).
Conclusions
Placement of the right ventricular lead in the RVA has a significantly lower DFT than placement of the lead in the RVOT.



Similar content being viewed by others
References
Askenazi, J., Alexander, J. H., Koenigsberg, D. I., Belic, N., & Lesch, M. (1984). Alteration of left ventricular performance by left bundle branch block simulated with atarioventricular sequential pacing. American Journal of Cardiology, 53, 99–104.
Saxon, L. A., Stevenson, W. G., Middlekauff, H. R., & Stevenson, L. W. (1993). Increased risk of progressive hemodynamic deterioration in advanced heart failure patients requiring permanent pacemakers. American Heart Journal, 125, 1306–1310.
Wilkoff, B. L., Cook, J. R., Epstein, A. E., et al. (2002). Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. Journal of the American Medical Association, 288, 3115–3123.
Kavanaugh, K. M., Belenkie, I., & Duff, H. J. (2008). Transmural temporospatial left ventricular activation during pacing from different sites: Potential implications for optimal pacing. Cardiovascular Research, 77, 81–88.
Giudici, M. C., Barold, S. S., Paul, D. L., Schrumpf, P. E., Van Why, K. J., & Orias, D. W. (2004). Right ventricular outflow tract placement of defibrillation leads: Five year experience. Pacing and Clinical Electrophysiology, 27, 443–446.
Gold, M. R., Higgins, S., Klein, R., et al. (2002). Efficacy and temporal stability of reduced safety margins for ventricular defibrillation: Primary results from the Low Energy Safety Study (LESS). Circulation, 105, 2043–2048.
Lubinski, A., Lewicka-Nowak, E., Krolak, T., et al. (2000). Implantation and follow-up of ICD leads implanted in the right ventricular outflow tract. Pacing and Clinical Electrophysiology, 23, 1996–1998.
Shorofsky, S. R., Peters, R. W., Rashba, E. J., & Gold, M. R. (2004). Comparison of step-down and binary search algorithms for determination of defibrillation threshold in humans. Pacing and Clinical Electrophysiology, 27, 218–220.
Zipes, D. P., Fisher, J., King, R. M., Nicoll, A. debB., & Jolly, W. W. (1975). Termination of ventricular fibrillation in dogs by depolarizing a critical amount of myocardium. American Journal of Cardiology, 36, 37–44.
Singer, I., & Lang, D. (1992). Defibrillation threshold: Clinical utility and therapeutic implications. Pacing and Clinical Electrophysiology, 15, 932–949.
Schuder, J. C., Stoeckle, M. D., & Dolan, A. M. (1964). Transthoracic ventricular defibrillation and square-wave stimuli, one-half cycle, one cycle, and multicycle waveforms. Circulation Research, 15, 258–264.
Jones, D. L., Irish, W. D., & Klein, G. J. (1991). Defibrillation efficacy. Comparison of defibrillation threshold versus dose–response curve determination. Circulation Research, 69, 45–51.
Strickberger, S. A., Daoud, E. G., Davidson, T., et al. (1997). Probability of successful defibrillation at multiples of the defibrillation energy requirement in patients with an implantable defibrillator. Circulation, 96, 1217–1223.
Schwartzman, D., Concato, J., Ren, J.-F., et al. (1996). Factors associated with successful implantation of nonthoracotomy defibrillation lead systems. American Heart Journal, 131, 1127–1136.
Shukla, H. H., Flaker, G. C., Jayam, V., & Roberts, D. (2003). High defibrillation thresholds in transvenous biphasic implatable defibrillators: Clinical predictors and prognostic implications. Pacing and Clinical Electrophysiology, 26, 44–48.
Pinski, S. L., Vanerio, G., Castle, L. W., et al. (1991). Patients with a high defibrillation threshold: Clinical characteristics, management, and outcome. American Heart Journal, 122, 89–95.
Hohnloser, S. H., Dorian, P., Roberts, R., et al. (2006). Effect of amiodarone and sotalol on ventricular defibrillation threshold: The optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial. Circulation, 114, 104–109.
Epstein, A. E., Ellenbogen, K. A., Kirk, K. A., Kay, G. N., Dailey, S. M., & Plumb, V. J. (1992). Clinical characteristics and outcome of patients with high defibrillation thresholds. A multicenter study. Circulation, 86, 1206–1216.
Leong-Sit, P., Gula, L. J., Diamantouros, P., et al. (2006). Effect of defibrillation testing on management during implantable cardioverter–defibrillator implantation. American Heart Journal, 152, 1104–1108.
Natale, A., Sra, J., Axtell, K., et al. (1994). Preliminary experience with a hybrid nonthoracotomy defibrillating system that includes a biphasic device: Comparison with a standard monophasic device using the same lead system. Journal of the American College of Cardiology, 24, 406–412.
Schwartzman, D., Callans, D. J., Gottlieb, C. D., Heo, J., & Marchlinski, F. E. (1996). Early postoperative rise in defibrillation threshold in patients with nonthoracotomy defibrillation lead systems: Attenuation with biphasic shock waveforms. Journal of Cardiovascular Electrophysiology, 7, 483–493.
Strickberger, S. A., Ching Man, K., Daoud, E., et al. (1995). Effect of first-phase polarity of biphasic shocks on defibrillation threshold with a single transvenous lead system. Journal of the American College of Cardiology, 25, 1605–1608.
Olsovsky, M. R., Shorofsky, S. R., & Gold, M. R. (1998). Effect of shock polarity on biphasic defibrillation thresholds using an active pectoral lead system. Journal of Cardiovascular Electrophysiology, 9, 350–354.
Schauerte, P., Stellbrink, C., Schöndube, F. A., et al. (1997). Polarity reversal improves defibrillation efficacy in patients undergoing transvenous cardioverter defibrillator implantation with biphasic shocks. Pacing and Clinical Electrophysiology, 20, 301–306.
Manolis, A. S., Chiladakis, J., Maounis, T. N., Vassilikos, V., & Cokkinos, D. V. (2000). Two-coil versus single-coil transvenous cardioverter–defibrillator systems: Comparative data. Pacing and Clinical Electrophysiology, 23, 1999–2002.
Rinaldi, C. A., Simon, R. D., Geelen, P., et al. (2003). A randomized prospective study of single coil versus dual coil defibrillation in patients with ventricular arrhythmias undergoing implantable cardioverter defibrillator therapy. Pacing and Clinical Electrophysiology, 26, 1684–1690.
Rashba, E. J., Bonner, M., Wilson, J., Shorofsky, S. R., Peters, R. W., & Gold, M. R. (2003). Distal right ventricular coil position reduces defibrillation thresholds. Journal of Cardiovascular Electrophysiology, 14, 1036–1040.
Winter, J., Zimmerman, N., Lidolt, H., et al. (2000). Optimal method to achieve consistently low defibrillation energy requirements. American Journal of Cardiology, 86(9A), 71K–75K.
Friedman, P. A., Rasmussen, M. J., Grice, S., Trusty, J., Glikson, M., & Stanton, M. S. (1999). Defibrillation thresholds are increased by right-sided implantation of totally transvenous implantable cardioverter defibrillators. Pacing and Clinical Electrophysiology, 22, 1186–1192.
Almquist, A. K., Montgomery, J. V., Haas, T. S., & Maron, B. J. (2005). Cardioverter–defibrillator implantation in high-risk patients with hypertrophic cardiomyopathy. Heart Rhythm, 2, 814–819.
Tang, A. S., Hendry, P., Goldstein, W., Green, M. S., & Luge, M. (1996). Nonthoracotomy implantation of cardioverter defibrillators: Preliminary experience with a defibrillation lead placed at the right ventricular outflow tract. Pacing and Clinical Electrophysiology, 19, 960–964.
Acknowledgements
This study was funded by the Duluth Clinic Foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mollerus, M., Lipinski, M. & Munger, T. A randomized comparison of defibrillation thresholds in the right ventricular outflow tract versus right ventricular apex. J Interv Card Electrophysiol 22, 221–225 (2008). https://doi.org/10.1007/s10840-008-9254-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10840-008-9254-x